Read More

What’s Going On With Pfizer On Thursday? Pharma Giant’s Shares Tick Lower

Pfizer Inc. reported that its Phase 3 CIFFREO study on Duchenne muscular dystrophy (DMD) gene therapy did not meet its primary effectiveness goal. Despite efforts to improve motor functions in boys aged 4 to 7 using a modified human dystrophin gene, the trial showed no significant progress, affecting Pfizer's quest for new treatments as it diversifies beyond its COVID-19 portfolio.

PFE

Read More

Walmart’s Bold Move to Digital Shelf Labels Is Transforming Retail And Their Stock Is Outperforming The S&P 500

Walmart is modernizing its operations by introducing digital shelf labels (DSLs) aiming to enhance customer service and simplify in-store processes. Walmart plans to implement DSLs in approximately 2,300 stores. Walmart's stock performance has experienced a year-to-date increase of 26%, outperforming the S&P 500.

WMT